Hurlen, Mette <br/><br/>
Warfarin, aspirin, or both after myocardial infarction.  [electronic resource] 

 -  The New England journal of medicine  Sep 2002 
 - 969-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa020496  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--adverse effects<br/>Aspirin--adverse effects<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Intracranial Thrombosis--prevention & control<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Secondary Prevention<br/>Warfarin--adverse effects